EDITORIAL | |
Bolstering the safety profile of patients with multiple morbidities receiving polypharmacy: explicit tools to address drug-drug interactions
Daniel Sevilla-Sánchez Farm Hosp. 2021;45(4):161-2 |
|
Centralized drug compounding units: an essential driver of patient safety
Ana Herranz, Sagrario Pernia Farm Hosp. 2021;45(4):163-4 |
|
ORIGINALS | |
Baricitinib and tofacitinib in patients with rheumatoid arthritis: results of regular clinical practice
Lara González-Freire, Rosa María Giménez-Candela, Susana Castro-Luaces, Ana Belén Veiga-Villaverde, Carlos Crespo-Diz Farm Hosp. 2021;45(4):165-9 |
|
Evaluation of antithrombotic treatment in institutionalized geriatric patients with nonvalvular atrial fibrillation
Javier Alaba-Trueba, Enrique Arriola-Manchola, Alexander Ferro-Uriguen, Idoia Beobide-Tellería, Silvia Martínez-Arrechea Farm Hosp. 2021;45(4):170-5 |
|
REVISIONS | |
Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review
María Sáez-Garrido, Alberto Espuny-Miró, Agustina Ruiz-Gómez, María Sacramento Díaz-Carrasco Farm Hosp. 2021;45(4):184-92 |
|
ORIGINALS IN BRIEF | |
Prevalence of adverse drug events in emergency departments. FARM-URG multi-center project
Jesús Ruiz-Ramos, Rosario Santolaya-Perrín, M.ª Ángeles García-Martín, Paloma Sempere-Serrano, Montserrat Alonso-Díaz, Beatriz Calderón-Hernanz y Grupo de trabajo REDFASTER de la Sociedad Española de Farmacia Hospitalaria Farm Hosp. 2021;45(4):176-9 |
|
Development of the @Antidotos_bot chatbot tool for poisoning management
Marta García-Queiruga, Carla Fernández-Oliveira, María José Mauríz-Montero, Ángeles Porta-Sánchez, Luis Margusino-Framiñán, Isabel Martín-Herranz Farm Hosp. 2021;45(4):180-3 |
|
SPECIAL ARTICLE | |
Face masks against the background of the COVID 19 pandemic: legal considerations about their use
Miriam Fraga-García, Amparo Nácher-Alonso, Octavio Díez-Sales Miriam Fraga-García, Amparo Nácher-Alonso, Octavio Díez-Sales |
|
Classification of antineoplastic drug-induced tissue damage: a Consensus of the Spanish Oncology Pharmacy Group
Asunción Albert-Marí, M.ª Ángeles Gil-Lemus, David Conde-Estévez, Begoña San José-Ruiz, Inmaculada Jiménez-Pulido, M.ª Jesús Esteban-Mensua, Ana Cristina Cercós-Lletí, M.ª Sacramento Díaz-Carrasco Farm Hosp. 2021;45(4):198-203 |
|
Time to review how injectable medicines are prepared and administered in European hospitals
David H. Cousins, María José Otero, Étienne Schmitt Farm Hosp. 2021;45(4):204-9 |
|
OTHERS | |
Erratum found in «Farmacia Hospitalaria. 2021;45(1):32-40»
Montserrat Pérez-Encinas, Ana Lozano-Blázquez, Javier García-Pellicer, Inmaculada Torre-Lloveras, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernández; en representación de la Junta de Gobierno de la Sociedad Española de Farmacia Hospitalaria (SEFH) 2011-2019 Farm Hosp. 2021;45(4):218 |
|
COMPLETE JOURNAL | |
PROTOCOLO | |
Pharmacist-led intervention on potentially inappropriate prescription in patients with polypharmacy: PHARM-PC clinical trial protocol
Jesús Martínez-Sotelo, Manel Pinteño-Blanco, Rosario García-Ramos, Joan Llobera-Cànaves, María Isabel Cadavid-Torres Farm Hosp. 2021;45(4):210-5 |
|
A new definition of pharmaceutical care: No, without consensus (Opinion on Barbate Document
Flor Álvarez de Toledo, Pilar Gascón, Miguel Ángel Gastelurrutia, Ana Dago Farm Hosp. 2021;45(4):216-7. |
|